APA

Kaufmann M., Maass N., Costa S. D., Schneeweiss A., Loibl S., Sütterlin M. W., Schrader I., Gerber B., Bauer W., Wiest W., Tomé O., Distelrath A., Hagen V., Kleine-Tebbe A., Ruckhaeberle E., Mehta K. & von Minckwitz G. (20110509). First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. : European journal of cancer (Oxford, England : 1990).

Chicago

Kaufmann M, Maass N, Costa S D, Schneeweiss A, Loibl S, Sütterlin M W, Schrader I, Gerber B, Bauer W, Wiest W, Tomé O, Distelrath A, Hagen V, Kleine-Tebbe A, Ruckhaeberle E, Mehta K and von Minckwitz G. 20110509. First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. : European journal of cancer (Oxford, England : 1990).

Harvard

Kaufmann M., Maass N., Costa S. D., Schneeweiss A., Loibl S., Sütterlin M. W., Schrader I., Gerber B., Bauer W., Wiest W., Tomé O., Distelrath A., Hagen V., Kleine-Tebbe A., Ruckhaeberle E., Mehta K. and von Minckwitz G. (20110509). First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. : European journal of cancer (Oxford, England : 1990).

MLA

Kaufmann M, Maass N, Costa S D, Schneeweiss A, Loibl S, Sütterlin M W, Schrader I, Gerber B, Bauer W, Wiest W, Tomé O, Distelrath A, Hagen V, Kleine-Tebbe A, Ruckhaeberle E, Mehta K and von Minckwitz G. First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. : European journal of cancer (Oxford, England : 1990). 20110509.